Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico

Background: About 60% of patients with polycystic ovary syndrome (PCOS) have insulin resistance, predisposing them to the premature coronary disease and type 2 -diabetes mellitus. However, the history of metabolic disorders in family members of patients with PCOS has been seldom documented in the li...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benítez M,Ricardo, Sir-Petermann,Teresa, Palomino A,Alberto, Angel B,Bárbara, Maliqueo Y,Manuel, Pérez B,Francisco, Calvillán C,Marcelo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2001
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000700001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872001000700001
record_format dspace
spelling oai:scielo:S0034-988720010007000012005-11-22Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquísticoBenítez M,RicardoSir-Petermann,TeresaPalomino A,AlbertoAngel B,BárbaraMaliqueo Y,ManuelPérez B,FranciscoCalvillán C,Marcelo Insulin resistance Polycystic ovary syndrome Reproductive, medicine Background: About 60% of patients with polycystic ovary syndrome (PCOS) have insulin resistance, predisposing them to the premature coronary disease and type 2 -diabetes mellitus. However, the history of metabolic disorders in family members of patients with PCOS has been seldom documented in the literature. Aim: To evaluate the family profile of metabolic disorders of PCOS patients and to determine their relative risk of developing one of them in comparison to a control group. Patients and Methods: Sixty PCOS patients were evaluated. The control group were 60 normal women. The data were obtained from the clinical history and personal interview with the patients, the controls and their relatives (brothers, parents and grandparents). The metabolic disorders considered were: dyslipidemia, obesity, hypertension and diabetes. Results: The ages were similar between groups (PCOS: 24.0 ± 6.3; control group: 24.8 ± 6.2 years). The prevalence of metabolic disorders was 62% in the relatives of the PCOS patients and 27.8% in the relatives of the control group (p <0.005). The probability to develop a metabolic disorder within the family was 2.7 (2.2-3.3) fold higher in the PCOS group compared to the control group. The risk of developing hypertension, dyslipidemia, obesity and diabetes was 2.1 (1.5-2.9); 1.8 (1.5-2.7); 3.6 (2.6-4.9) and 2.7 (1.8-3.9), respectively, in the PCOS group compared to the control group. Conclusions: The probability of finding a metabolic disorder in the families of PCOS patients, is 2.7 fold higher than in the control group families. The metabolic disorders are more frequent in parents and grandparents of the PCOS patients than in those of normal women (Rev Méd Chile 2001; 129: 707-12)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.7 20012001-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000700001es10.4067/S0034-98872001000700001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Insulin resistance
Polycystic ovary syndrome
Reproductive, medicine
spellingShingle Insulin resistance
Polycystic ovary syndrome
Reproductive, medicine
Benítez M,Ricardo
Sir-Petermann,Teresa
Palomino A,Alberto
Angel B,Bárbara
Maliqueo Y,Manuel
Pérez B,Francisco
Calvillán C,Marcelo
Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
description Background: About 60% of patients with polycystic ovary syndrome (PCOS) have insulin resistance, predisposing them to the premature coronary disease and type 2 -diabetes mellitus. However, the history of metabolic disorders in family members of patients with PCOS has been seldom documented in the literature. Aim: To evaluate the family profile of metabolic disorders of PCOS patients and to determine their relative risk of developing one of them in comparison to a control group. Patients and Methods: Sixty PCOS patients were evaluated. The control group were 60 normal women. The data were obtained from the clinical history and personal interview with the patients, the controls and their relatives (brothers, parents and grandparents). The metabolic disorders considered were: dyslipidemia, obesity, hypertension and diabetes. Results: The ages were similar between groups (PCOS: 24.0 ± 6.3; control group: 24.8 ± 6.2 years). The prevalence of metabolic disorders was 62% in the relatives of the PCOS patients and 27.8% in the relatives of the control group (p <0.005). The probability to develop a metabolic disorder within the family was 2.7 (2.2-3.3) fold higher in the PCOS group compared to the control group. The risk of developing hypertension, dyslipidemia, obesity and diabetes was 2.1 (1.5-2.9); 1.8 (1.5-2.7); 3.6 (2.6-4.9) and 2.7 (1.8-3.9), respectively, in the PCOS group compared to the control group. Conclusions: The probability of finding a metabolic disorder in the families of PCOS patients, is 2.7 fold higher than in the control group families. The metabolic disorders are more frequent in parents and grandparents of the PCOS patients than in those of normal women (Rev Méd Chile 2001; 129: 707-12)
author Benítez M,Ricardo
Sir-Petermann,Teresa
Palomino A,Alberto
Angel B,Bárbara
Maliqueo Y,Manuel
Pérez B,Francisco
Calvillán C,Marcelo
author_facet Benítez M,Ricardo
Sir-Petermann,Teresa
Palomino A,Alberto
Angel B,Bárbara
Maliqueo Y,Manuel
Pérez B,Francisco
Calvillán C,Marcelo
author_sort Benítez M,Ricardo
title Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
title_short Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
title_full Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
title_fullStr Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
title_full_unstemmed Prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
title_sort prevalencia familiar de patologías metabólicas en pacientes con síndrome de ovario poliquístico
publisher Sociedad Médica de Santiago
publishDate 2001
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000700001
work_keys_str_mv AT benitezmricardo prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
AT sirpetermannteresa prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
AT palominoaalberto prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
AT angelbbarbara prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
AT maliqueoymanuel prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
AT perezbfrancisco prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
AT calvillancmarcelo prevalenciafamiliardepatologiasmetabolicasenpacientesconsindromedeovariopoliquistico
_version_ 1718435979826561024